Originally published In Press as doi:10.1074/jbc.M001770200 on May 2, 2000
J. Biol. Chem., Vol. 275, Issue 33, 25508-25515, August 18, 2000
Calcium Affinity, Cooperativity, and Domain Interactions of
Extracellular EF-hands Present in BM-40*
Elisabeth
Busch
,
Erhard
Hohenester§¶,
Rupert
Timpl
,
Mats
Paulsson
, and
Patrik
Maurer
**
From the
Institute for Biochemistry, Medical Faculty,
University of Cologne, 50931 Cologne, Germany, the
§ Biophysics Section, Blackett Laboratory and the Division
of Medicine, Imperial College, London, SW7 2BZ, United Kingdom, and
the
Max-Planck-Institut für Biochemie, 82152 Martinsried, Germany
Received for publication, March 3, 2000, and in revised form, April 17, 2000
 |
ABSTRACT |
The structure and function of cytosolic
Ca2+-binding proteins containing EF-hands are well
understood. Recently, the presence of EF-hands in an extracellular
protein was for the first time proven by the structure determination of
the EC domain of BM-40 (SPARC (for secreted protein acidic and
rich in cysteine)/osteonectin) (Hohenester, E., Maurer, P.,
Hohenadl, C., Timpl, R., Jansonius, J. N., and Engel, J. (1996) Nat. Struct. Biol. 3, 67-73). The structure
revealed a pair of EF-hands with two bound Ca2+ ions. Two
unusual features were noted that distinguish the extracellular EF-hands
of BM-40 from their cytosolic counterparts. An insertion of one amino
acid into the loop of the first EF-hand causes a variant
Ca2+ coordination, and a disulfide bond connects the
helices of the second EF-hand. Here we show that the extracellular
EF-hands in the BM-40 EC domain bind Ca2+ cooperatively and
with high affinity. The EC domain is thus in the
Ca2+-saturated form in the extracellular matrix, and the
EF-hands play a structural rather than a regulatory role. Deletion
mutants demonstrate a strong interaction between the EC domain and the neighboring FS domain, which contributes about 10 kJ/mol to the free
energy of binding and influences cooperativity. This interaction is
mainly between the FS domain and the variant EF-hand 1. Certain mutations of Ca2+-coordinating residues changed affinity
and cooperativity, but others inhibited folding and secretion of the EC
domain in a mammalian cell line. This points to a function of EF-hands
in extracellular proteins during biosynthesis and processing in the
endoplasmic reticulum or Golgi apparatus.
 |
INTRODUCTION |
The EF-hand is a highly conserved Ca2+-binding motif
found in a large number of intracellular proteins. EF-hands, as present in calmodulin, troponin C, and calcineurin, are responsible for signal
transduction by the second messenger Ca2+, leading to the
activation or inactivation of numerous and diverse target proteins and
thus influencing a wide range of cellular processes (1-4). The term
EF-hand was introduced by Kretsinger and Nockolds (5) in describing the
structure of parvalbumin. Two helices (E and F in parvalbumin) flank a
loop of 12 amino acids in which the Ca2+ ion is 7-fold
coordinated in a pentagonal-bipyramidal arrangement. The
Ca2+ ion is coordinated by side chain oxygen atoms at the
X, Y, and Z vertices, by a backbone carbonyl at
Y, by a water
molecule at
X, and by a carboxylate (mostly glutamate) at
Z, which
makes a crucial bidentate interaction with the metal ion (see Fig. 1). This canonical EF-hand structure was subsequently found in a number of
proteins of the Ca2+ second messenger system. Usually,
EF-hands occur in pairs, although in some cases one or even both
EF-hands in a pair may no longer be functional because of mutations of
Ca2+-coordinating residues (for reviews see Refs.
6-8).
Several variations of the canonical Ca2+-binding mode are
known. In the S100 subfamily of EF-hand proteins, two amino acids are
inserted in the N-terminal EF-hand loop, while the C-terminal EF-hand
is of the canonical type. The insertions lead to a rearrangement in the
loop, such that the Ca2+ ion is coordinated by backbone
carbonyl oxygens at positions X, Y, Z and -Y, with the bidentate ligand
at -Z providing the only side chain oxygen atoms (9). Despite the
unusual coordination of this site, the affinities of the two EF-hands
for Ca2+, e.g. in calbindin D9k, are nearly
identical (10). A further variation of the canonical EF-hand was found
in myosin essential light chain. The loop in the first EF-hand
of the EF-hand pair also contains two inserted amino acids but at
different positions compared with S100 proteins. In essential light
chain the insertions result in a more pronounced rearrangement of
Ca2+ ligands, with several residues coordinating
Ca2+ with both their backbone and side chain oxygens (11,
12). Finally, in the Ca2+-binding domain of calpain, the
first of the five EF-hands binds Ca2+ noncanonically. This
EF-hand lacks the typical side chains at positions X and Y and uses a
carbonyl oxygen and a second water molecule instead (13, 14).
BM-40 (SPARC (for secreted protein acidic and rich in
cysteine)/osteonectin) is the only example of an extracellular EF-hand protein that is secreted by virtue of a classic signal peptide and for
which a structure determination has proved the presence of EF-hands
(15, 16). BM-40 is an abundant glycoprotein and has been suggested to
participate in the modulation of cell-matrix interactions, bone
mineralization, wound repair, and angiogenesis (17). It is highly
expressed in some malignant tumors and has been reported to play a
crucial role in the tumorigenicity of human melanomas (18).
Developmental anomalies are induced by overexpressing or suppressing
BM-40 in nematodes (19, 20). Furthermore, microinjection of BM-40 RNA,
protein, peptides, or antibodies against BM-40 interfere with
Xenopus embryonic development (21, 22). In contrast,
deletion of the BM-40 gene in mice resulted in a relatively mild
phenoptype, namely late onset cataract formation in the eye, whereas
development proceeded normally (23, 24). However, further defects, such
as severe osteopenia, are under investigation (25). It is suspected
that homologous proteins, such as SC1, QR1, TSC-36, testican-1, or
testican-2 (26-30) may compensate for several of the reported
functions of BM-40 during murine embryonic development.
BM-40 is a modular protein built from three domains. A short N-terminal
region (domain I), rich in glutamic acid residues, binds several
Ca2+ ions with low affinity (Kd = 5-10
mM) (31). This is followed by a region homologous to
follistatin (FS domain) and an autonomously folding C-terminal
Ca2+-binding EC domain. A single EF-hand was predicted in
the EC domain of BM-40 (32), and Ca2+ binding was
interpreted as being to a single site (31, 33, 34). However, the
structures of the EC domain and the pair of FS and EC domains revealed
a pair of EF-hands in the EC domain, each with a bound Ca2+
ion (15, 16). Both EF-hands in BM-40 are of unusual structure; a
one-residue insertion into the Ca2+-coordinating loop of
the first EF-hand is accommodated by a cis-peptide bond,
which allows a peptide carbonyl to substitute for a
Ca2+-binding side chain. This novel variation explained why
even sophisticated search algorithms failed to detect both EF-hands in
BM-40. The second EF-hand has a canonical pattern of
Ca2+-coordinating residues but is circularized by a
disulfide bond between the flanking helices. A collagen-binding site in
the EC domain of BM-40, which is only active in the presence of
Ca2+, has been characterized by an alanine
mutagenesis screen (35).
One objective of the present investigation was to determine the
Ca2+ binding properties of the EF-hands of BM-40. Both the
variant and the canonical EF-hand were found to bind Ca2+
with high affinity, and there is positive cooperativity between the two
EF-hands. In addition, interactions with the neighboring FS domain
strongly influence the Ca2+ affinity of the EC domain. Some
mutations in the EF-hands designed to abolish Ca2+ binding
interfered with protein secretion, indicating an essential role of
Ca2+ binding for folding and secretion.
 |
EXPERIMENTAL PROCEDURES |
Nomenclature of Proteins and Mutants--
The sequence numbering
of human BM-40 (36) used starts at the N terminus obtained after
cleavage of the signal peptide. Secreted recombinant full-length human
BM-40 thus corresponds to amino acid residues 1-286. The designation
FS-EC (residues 51-286) is used for the fragment encompassing the FS
and EC domains but lacking the N-terminal acidic domain. The EC domain
encompasses residues 136-286. The sequence of both EF-hand loops
within the EC domain and the point mutations introduced are shown in
Fig. 1. The nomenclature for the point
mutants includes the domain context, the corresponding EF-hand, and the
substitution. For instance, EC-EF1-E234K describes a point mutation
introduced in the EC domain in which Glu234 in
EF-hand 1 (EF1) occupying position
Z of the pentagonal bipyramid is
changed to lysine. The fragment FS-EC-
C lacks helix C (residues 196-203) of the EC domain (35).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Amino acid sequences of EF-hand motifs in
BM-40 and point mutants. Residues coordinating Ca2+
with side chain oxygen atoms are boxed in black,
whereas residues using backbone carbonyl oxygens are boxed
in gray (16). The Ca2+ coordination of canonical
EF-hands is indicated by letters denoting the position of
the coordinating residues in the pentagonal-bipyramid. The glutamic
acid at position Z chelates Ca2+ with both oxygens of its
side chain. Note that EF1 is a variant of the canonical EF-hand motif.
The insertion of His224 induces the coordination of
Ca2+ via the backbone carbonyl oxygen of
Pro225.
|
|
Construction of BM-40 Mutants--
The point mutant EC-EF1-E234K
was produced by the method of Deng and Nickoloff (37) using the
transformer site-directed mutagenesis kit
(CLONTECH) and the cDNA encoding the EC domain of human BM-40 (34). The mutation primer
5'-CCCACACCAAGCTGGCGCCACTGCGT contained the
change of the GAG codon for Glu234 to the AAG codon
of lysine. An additional silent T to G mutation resulted in a novel
NarI site which was used to identify mutated clones. Mutagenesis was
performed as described by the manufacturer (CLONTECH, CA). Production and purification of
full-length BM-40, deletion mutants FS-EC and EC, and mutants
BM-40-EF2-D257K and BM-40-EF2-E268K was done as described previously
(33, 34). cDNA fragments (269 base pairs) containing the mutations
in EF2 were obtained by KpnI/XhoI restriction
cleavages of BM-40-EF2-D257K and BM-40-EF2-E268K (33) and were cloned
into the cDNA of the EC domain resulting in EC-EF2-D257K and
EC-EF2-E268K. The double mutant EC-EF1,2-E234K,E268K was produced by
subcloning the 136-base pair NcoI/XhoI fragment
of EC-EF2-E268K into EC-EF1-E234K fragment. NheI/XhoI fragments of EC-EF1-E234K,
EC-EF2-D257K, EC-EF2-E268K, and EC-EF1,2-E234K,E268K were excised and
ligated with the NheI/XhoI restricted episomal
expression vector pCEP-Pu (38). This vector contains the signal peptide
of BM-40 and enables the secretion of recombinant protein into the cell
culture media. Correct mutagenesis and cloning was verified by
cycle sequencing using the Alfexpress DNA sequencer (Amersham
Pharmacia Biotech).
Human embryonic kidney cells (EBNA-293) were transfected with 20 µg of pCEP-Pu vectors using LipofectAMINE (Life Technologies, Inc.)
or electroporation. Cells were selected with 0.5 µg/ml puromycin in
Dulbecco's modified Eagle's medium/Ham's F-12 medium with 10% fetal
calf serum for 14 days as described (38). For purification of proteins
from the cell culture media, cells were maintained under serum-free
conditions and culture medium was collected every 2 days.
Reverse Transcription-Polymerase Chain Reaction of Transfected
Cellular mRNA--
Transfected and nontransfected EBNA-293 cells
were trypsinized from confluent plates, and 107 cells were
used for isolation of mRNA performed according to the
manufacturer's protocol (Amersham Pharmacia Biotech). mRNA concentrations were determined using UV spectroscopy.
RT-PCR1 was performed in a
one-tube reaction by addition of 1 unit of reverse transcriptase and 1 unit of Taq polymerase in RT-PCR buffer (0.1 M
Tris/HCl, pH 8.4, 0.5 M KCl, 25 mM
MgCl2, 1 mM dithiothreitol, 0.2% gelatin,
6.25% W1, 2.5 mM of each dNTP). After addition of 100 ng
of mRNA, 50 pmol of sense primer 5'-GTTCCCAGCACCATGAGGG and 50 pmol
of antisense primer 5'-GATCCTCGAGT-TAGATCACAAGATCC reverse
transcription was allowed to proceed for 25 min at 37 °C. Five
cycles of polymerase chain reaction were then performed at an annealing
temperature of 50 °C followed by 30 cycles at an annealing
temperature of 65 °C. Denaturation and elongation temperatures were
95 and 72 °C, respectively. Half of the reaction product was
subjected to electrophoresis on a 1.5% agarose gel and stained with
ethidium bromide. In controls reverse transcriptase was omitted.
Immunoblot of Transfected EBNA-293 Cells--
Transfected
EBNA-293 cells of confluent plates (diameter, 10 cm) were washed with
phosphate-buffered saline and lysed with 1 ml of 0.5% Triton X-100.
Aliquots of serum-free culture medium (1 ml) were precipitated with
trichloroacetic acid. The pellets were resuspended in reducing sample
buffer. Resuspended pellets and cell lysates were subjected to
electrophoresis in 15% SDS-PAGE gels according to Laemmli (39).
Proteins were transferred onto nitrocellulose, and blocking was done
with 5% milk powder solution. A rabbit polyclonal antiserum against
human BM-40 (40) was used as a primary antibody, and detection was
performed with a goat antibody against rabbit IgG coupled to peroxidase
(DAKO, Denmark) and the enhanced chemoluminescence kit (Amersham
Pharmacia Biotech).
Purification of EC-EF1-E234K and EC-EF2-D257K--
Serum-free
cell culture media (about 2.5 liters) were dialyzed against 50 mM Tris/HCl, pH 8.6, and subjected to anion exchange chromatography on DEAE-Sepharose. Elution was performed with a linear
salt gradient from 0 to 1 M NaCl. After dialysis of pooled fractions, recombinant EC domains were separated on MonoQ (Amersham Pharmacia Biotech) equilibrated in the same buffer. Elution was done
with a linear salt gradient (0- 0.5 M NaCl, containing 2 M urea). EC domains eluted in a broad peak between 0.15 and
0.4 M NaCl. Fractions containing the recombinant proteins
were pooled and applied to a Sephadex G-75 column equilibrated in 50 mM Tris/HCl, pH 8.6, 150 mM NaCl. Final
concentration was achieved on a Resource Q column followed by extensive
dialysis against the appropriate buffer.
Circular Dichroism--
Proteins were dialyzed against 5 mM Tris/HCl, pH 7.4, or 50 mM Tris/HCl, pH 7.4, 150 mM NaCl (TBS). Protein concentrations were calculated
from the absorption at 280 nm as described (34). For the EC domain and
EC domain mutants, an extinction coefficient of 1.39 ml
mg
1 cm
1 was used (41). CD spectra in the
far UV region were recorded in a thermostated quartz cell of 1-mm
optical path length in a Jasco 715 CD spectropolarimeter. Spectra were
measured with the protein dissolved in the appropriate dialysis buffer,
after adding 2 mM CaCl2, and after subsequent
addition of 3 mM EDTA. Molar ellipticities [
]
(expressed in degrees cm2 dmol
1) were
calculated on the basis of a mean residue molecular mass of 110 Da. Ten
spectra were accumulated to improve the signal/noise ratio. Spectra of
buffers were subtracted. The percentage of change in circular dichroism
at 222 nm was calculated as
[
]222 = 100 × ([
]Ca
[
]EDTA)/[
]Ca with
[
]Ca representing the signal at Ca2+
saturation and [
]EDTA representing the CD signal in
the presence of excess EDTA.
Fluorimetry and Ca2+ Titrations--
Fluorescence
was measured with a Perkin-Elmer LS50B spectrophotometer in 10-mm
pathlength rectangular cells at 25 °C. Intrinsic fluorescence was
excited at 280 nm for all recombinant proteins. Emission maxima were
between 333 and 337 nm. Spectra were recorded in TBS in the presence of
2 mM CaCl2 and after subsequent addition of 4 mM EDTA. The percentage of change in fluorescence intensity at 337 nm was calculated as
F337 = 100 × (FCa2+
FEDTA)/FCa2+
with FCa2+ representing the signal
at Ca2+ saturation and FEDTA
representing the fluorescence signal in the presence of excess EDTA.
Ca2+ titrations were performed with the EGTA/CaEGTA
buffering system as described by Tsien and Pozzan (42). 100 mM EGTA and 100 mM CaEGTA stock solutions were
purchased from Molecular Probes. An equilibrium dissociation
constant Kd = 35 nM for the CaEGTA
complex was used for the titrations in TBS. Proteins (about 1 µM) were dissolved in buffer containing 10 mM
EGTA, and fluorescence intensity was measured. Defined aliquots of the
solution were removed and substituted by the same volume of protein
dissolved at the same concentration in 10 mM CaEGTA, thus
increasing the free Ca2+ concentration while keeping the
protein concentration constant. This was repeated until finally the
fluorescence intensity was measured for protein in 10 mM
CaEGTA. Alternatively, proteins were dissolved in buffer containing 10 mM EGTA, and small aliquots of 100 mM CaEGTA
stock solutions were added. In this instance, fluorescence intensity
was corrected for dilution. Recombinant BM-40 mutants with low affinity
for Ca2+ (Kd>20 µM) were
directly titrated with CaCl2 in the absence of EGTA. The
degree of saturation Y was calculated from the signal S as
Y = (S
S0)/(SCa
S0), where SCa and
S0 represent the signals at Ca2+
saturation and zero Ca2+, respectively.
Data Evaluation--
Two potential mechanisms for binding of
Ca2+ to BM-40 and its mutants were considered. The
single-site model describes the change of the measured signal as a
function of the binding of a single Ca2+ ion to the protein
as shown in the following equation.
|
(Eq. 1)
|
The degree of saturation Y is then described by
Y = [Ca]/(Kd + [Ca]), where
[Ca] represents the free Ca2+ concentration and
Kd represents the equilibrium dissociation constant.
For a protein containing two binding sites, which may be either
independent (no cooperativity present) or interacting (cooperativity
present), four microscopic equilibrium dissociation constants are
needed to fully describe the situation. However, the spectroscopic
methods used do not allow for discrimination of Ca2+
binding to the individual sites, and thus the four dissociation constants cannot be resolved (44). We therefore used a macroscopic two-site model with two Ca2+-binding sites, in which
binding of one Ca2+ is described by the macroscopic
equilibrium dissociation constant KD1
followed by binding of a second Ca2+ with
KD2.
|
(Eq. 2)
|
This model also allows detection of cooperativity between the
two sites. If positive cooperativity is present,
KD2 will be less than 4 × KD1, because the second Ca2+
ion binds with higher affinity when the first site is occupied than
when it is empty. If there is no positive cooperativity, KD2 will be equal or greater than 4 × KD1. The degree of saturation can be
described by Y = ([PCa] + [PCa2])/[Ptot] with [PCa] and
[PCa2] representing the concentrations of the
corresponding Ca2+-bound protein species and
[Ptot] representing the total protein concentration.
Assuming that contributions to the fluorescence signal are identical
for PCa and PCa2 this equation can be transformed into the
following equation.
|
(Eq. 3)
|
The program COSY (43) or Grafit (Erithacus Software) were used
to fit both models to the experimental data with nonlinear least square
fit procedures.
Cooperativity in a two-site system can be characterized by

G, which gives the difference in free binding energies
between the binding to a given site when the other site is occupied and when the other site is empty. For calculation of this free energy of
interaction, 
G, knowledge of the microscopic
equilibrium dissociation constants is required. However, these are not
directly accessible from Ca2+ titrations. A lower limit of
the free energy of interaction 
G can be calculated
from the macroscopic KD values with 
G
=1 =
RT ln
(4·KD1/KD2)
(44). 
G
=1 is identical to

G if the microscopic affinity of both sites is
identical. If microscopic affinities are not identical,

G is always smaller than

G
=1.
 |
RESULTS |
BM-40 Binds Ca2+ with High Affinity and
Cooperativity--
The affinity of EF-hands for Ca2+
varies for the different cytosolic members of the EF-hand family with
dissociation constants (Kd) ranging from
nM to µM values. Our first aim was to
determine the affinities of the EF-hands of BM-40. We were unable to
obtain BM-40 in a sufficiently Ca2+-free form either by
dialysis against EDTA or Chelex-100 or by chromatography on an
EDTA-agarose column (data not shown). We therefore used an EGTA/CaEGTA
system (42) to follow Ca2+ binding. Briefly, this method
relies on the use of two stock solutions of 100 mM EGTA and
100 mM CaEGTA, respectively. The latter is exactly titrated
using a pH-metric method. Using different ratios of EGTA and CaEGTA,
the free Ca2+ concentrations in a solution can be adjusted
with high precision to [Ca2+]free = Kd × [CaEGTA/EGTA]. Knowledge of the
concentrations of residual Ca2+ from buffer solutions and
bound to proteins (usually between 1-20 µM) is not
necessary because this is buffered by the excess EGTA (normally 10 mM) in the system. For a residual Ca2+
concentration of 20 µM the error in the calculated free
Ca2+ concentration is less than 2%.
The reversible change in intrinsic fluorescence of full-length BM-40
(36) was used to monitor Ca2+ binding. A simple model of
one Ca2+ ion binding to BM-40 could not sufficiently
describe the measured values, which evidently follow a curve with a
steeper slope around the midpoint than predicted from the single-site
model. An appropriate description was achieved with the two-site model,
which enabled the determination of two macroscopic
KD values of KD1 = 490 nM and KD2 = 57 nM, respectively (Fig.
2A). The fact that
KD2 is much smaller than 4 × KD1 clearly demonstrates that positive
cooperativity is present because of interaction between the sites.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Ca2+ binding of BM-40 and its
fragments. Ca2+ binding was monitored by intrinsic
fluorescence with excitation at 280 nm and emission at 337 nm. The
fraction Y of the total change of flurorescence intensity is plotted
against the free Ca2+ concentration adjusted with the
EGTA/CaEGTA system. A, for full-length BM-40 two macroscopic
constants KD1 = 490 nM and
KD2 = 57 nM were obtained
from the best fit of the model with two binding sites to the
experimental data (solid line). Fitting a model with only
one binding site was insufficient (dashed line).
B, comparison of Ca2+ titrations for full-length
BM-40 ( ), the FS-EC domain pair ( ), and the EC domain ( ). Best
fit curves are shown as solid lines with
KD1 = 470 nM and
KD2 = 26 nM for FS-EC domain
pair and KD1 = 11750 nM and
KD2 = 56 nM for the EC
domain. In addition, the curve calculated with Kd = 870 nM for a model with one binding site in the EC domain
is shown as a dashed line.
|
|
Domain Interactions with the FS Domain Influence Ca2+
Affinity--
The change in fluorescence of the deletion mutant FS-EC
was also investigated in the EGTA/CaEGTA system. Cooperative high affinity binding of Ca2+ to FS-EC was observed (Fig.
2B). The affinity of FS-EC was very similar to that of
full-length BM-40 with macroscopic KD values of 470 and 26 nM. This indicates that the acidic domain I does not
significantly influence Ca2+ binding to the EC domain. In
contrast, removal of both domain I and the FS domain, resulting in the
isolated EC domain, strongly decreased Ca2+ affinity.
Macroscopic KD values of 11750 and 56 nM
were obtained as best fit parameters for the EC domain (Fig.
2B). Ca2+ affinity is on average 6-fold lower if
one compares (KD1 KD2)0.5, which
corresponds to a loss in total free binding energy of 9.9 kJ/mol (Table I).
Point Mutations in EF2 Disturb Folding and Secretion of the EC
Domain--
To investigate the influence of the individual EF-hands on
Ca2+ affinity and cooperativity we mutated the conserved
glutamic acid at position
Z to lysine, a mutation recently shown to
strongly decrease affinity of EF-hands (45-48). Because the two
disulfides of the EC domain are essential for proper folding, all
proteins were expressed in a eukaryotic expression system. When
analyzing cell culture supernatants of transfected EBNA-293 cells
recombinant EC domains with mutations EC-EF1-E234K and EC-EF2-D257K
were readily seen in an immunoblot (Fig.
3). However, EC-EF2-E268K as well as the
double mutant EC-EF1,2-E234K,E268K could not be detected in the medium
(Fig. 3). The presence of similar amounts of endogenous BM-40 shows
that the absence of the two mutants was not caused by cell death or a
general inhibition of the secretory pathway. To prove successful
transfection and selection of the EBNA-293 cells, we isolated mRNA
from transfected cells and performed RT-PCR with primers specific for
the recombinant EC domain. For all transfected cell lines the 540-base
pair cDNA fragment could be amplified demonstrating the presence of
the respective mRNAs (Fig.
4A). mRNA of endogenous
BM-40 was not amplified as the reverse primer partially spanned
noncoding region of the vector sequence. Next we prepared cell lysates
of the nonsecreting EC-EF2-E268K and EC-EF1,2-E234,268K cells. In an
immunoblot a faint band for both proteins could be detected (Fig.
4B). The intensity of the bands was comparable with that of
the endogenous BM-40 and presumably represents the small amount of
protein that is translated and processed in the endoplasmic reticulum
and/or Golgi apparatus.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblot of cell culture media. 1 ml
of serum-free cell culture medium transfected with EC-EF1-E234K,
EC-EF2-E268K, EC-EF2-D257K, EC-EF1,2-E234K,E268K, or from untransfected
cells (denoted EBNA 293) were separated by 15% SDS-PAGE under reducing
conditions, blotted onto a nitrocellulose membrane, and stained with an
anti-BM40 antiserum. Molecular masses of protein standards are given in
kDa. The arrowhead marks the endogenous BM-40, and the
arrow marks the EC domain.
|
|

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 4.
RT-PCR of mRNA from untransfected and
transfected cells (A) and immunoblot of cell lysates
(B). A, mRNA was isolated from
untransfected (EBNA 293) cells and cells transfected with EC-EF2-E268K,
EC-EF1,2-E234K,E268K, and EC-EF2-D257K. Reverse transcription and PCR
were performed with primers specific for the EC domain. Reaction
products were separated by agarose gel electrophoresis and stained with
ethidium bromide. B, cell lysates of transfected
EC-EF2-E268K and EC-EF1,2-E234K,E268K EBNA-293 cells were separated by
15% SDS-PAGE under reducing conditions, blotted onto a nitrocellulose
membrane, and stained with an antiserum against BM40. The
arrowhead marks the endogenous BM-40, and the
arrow marks the EC domain.
|
|
Point Mutations in EF-hands Abolish Cooperativity of
Ca2+ Binding--
Both EC-EF1-E234K and EC-EF2-D257K were
produced and could be purified to homogeneity from cell culture media
(Fig. 5), even though expression levels
were decreased compared with the nonmutated EC domain. The proteins
eluted in broad peaks from ion exchange columns, and as a consequence,
yields were very low (<25 µg/liter of medium). Nonetheless, circular
dichroism spectra demonstrated that the mutated EC domains in the
Ca2+-free form had similar folds to that of the nonmutated
EC domain (Fig. 6). Upon addition of
Ca2+, the EC domain showed a 39% decrease in molar
ellipticity at 222 nm, whereas only a 28% decrease was observed for
EC-EF1-E234K. The conformational change was even more compromised in
mutant EC-EF2-D257K, where the signal changed by only 10%.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
SDS-PAGE of the purified EC domain
mutants. Electrophoresis of the purified proteins EC-EF1-E234K and
EC-EF2-D257K was performed under nonreducing conditions. The gel was
stained with Coomassie Brillant Blue. Molecular masses of protein
standards are given in kDa.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Conformation of mutated EC domains. Far
UV circular dichroism spectra of the EC domain and its mutants
EC-EF1-E234K and EC-EF2-D257K were recorded in 5 mM
Tris/HCl, pH 7.4. Spectra were measured in the presence of 2 mM Ca2+ (solid line) and after
addition of 3 mM EDTA (dashed line).
|
|
In fluorescence studies, EC, EC-EF1-E234K, and EC-EF2-D257K showed
emission maxima at about 340 nm when excited at their excitation maxima
at 280 nm (data not shown). Titration of EC-EF1-E234K and EC-EF2-D257K
revealed no change in fluorescence at submicromolar Ca2+
concentrations. However, changes in intrinsic fluorescence intensities could be observed when Ca2+ concentrations were raised
significantly (Fig. 7). In contrast to
results obtained with the EC domain, analysis of Ca2+
titrations of EC-EF1-E234K and EC-EF2-D257K revealed no sign of
cooperativity. A model assuming a single binding site with Kd = 45 µM for EC-EF1-E234K and
Kd = 205 µM for EC-EF2-D257K,
respectively, could adequately describe the data (Fig. 7).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Ca2+ binding to EC domains with
mutated EF-hands. Ca2+ binding was monitored by
intrinsic fluorescence as described in the legend to Fig. 2.
Macroscopic constants KD1 = 11750 nM and KD2 = 56 nM resulted from the best fit of the model with two binding
sites to the experimental data of wild type EC domain ( ). Best fit
curves for EC-EF1-E234K ( ) and EC-EF2-D257K ( ) were obtained with
a model with one binding site. Corresponding dissociation constants
were Kd = 45 µM and
Kd = 205 µM, respectively. The loss of
cooperativity in the mutants is evident from the reduced slope of the
binding curves.
|
|
The mutations EF2-D257K and EF2-E268K have been introduced previously
into full-length BM-40 (BM-40-EF2-D257K and BM-40-EF2-E268K) (33). To
analyze cooperativity in the context of the full-length protein, we
reinvestigated Ca2+ binding to these mutants. The
fluorescence change upon Ca2+ addition could be described
with a model assuming a single binding site, and a
Kd = 0.22 µM for BM-40-EF2-D257K was
evaluated (Fig. 8), confirming the
earlier results (33). For BM-40-EF2-E268K, the Ca2+
affinity was clearly decreased and not cooperative
(Kd = 1.2 µM). In the mutant
FS-EC-
C, the helix C is lacking in the EC domain. This mutation
leads to enhanced collagen binding to the EC domain (35). The structure
of FS-EC-
C was recently solved and showed two Ca2+ ions
bound to the EF-hands (35). The affinity of FS-EC-
C for Ca2+ was 10-fold reduced relative to FS-EC when
(KD1KD2)0.5
are compared, but the cooperativity between the sites was enhanced by
the deletion (Fig. 8 and Table I).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Ca2+ binding to
full-length BM-40 with mutated EF-hands. Ca2+ binding
was monitored by intrinsic fluorescence as described in the legend to
Fig. 2. Dissociation constants KD1 = 490 nM and KD2 = 57 nM resulted from the best fit of the model with two binding
sites to the experimental data for full-length BM-40 ( ). The best
fit curve for BM-40-EF2-D257K ( ) assumed one binding site with
Kd = 220 nM. Dissociation constants
KD1 = 21540 nM and
KD2 = 52 nM were obtained
for FS-EC- C ( ). The best fit curve for BM-40-EF2-E268K ( )
assumed one binding site with Kd = 1200 nM. The loss of cooperativity in the mutants EF2-D257K and
EF2-E268K is evident from the reduced slope of the binding
curves.
|
|
 |
DISCUSSION |
Cytosolic EF-hand proteins are designed to fulfill different
functions at low Ca2+ concentrations in the resting cell
(about 0.1 µM Ca2+) and when the cell has
been activated (about 10 µM Ca2+). Their
affinity for Ca2+ is accordingly tuned to this
concentration range, allowing the proteins to switch from
Ca2+-free to Ca2+-bound conformations upon
activation. BM-40 is the only example so far of an extracellular
protein containing EF-hands of which the three-dimensional structure is
known. The role of Ca2+-binding to extracellular EF-hands
is rather mysterious, because the extracellular free Ca2+
concentration is high (about 1.2 mM) and believed to be
constant (49). The experiments presented here were designed to shed
some light on the possible function(s) of extracellular EF-hands.
We have used a Ca2+ buffering system that allows precise
adjustment of Ca2+ concentrations in the nanomolar range to
examine Ca2+ binding by BM-40. The two EF-hands in BM-40
were found to bind Ca2+ with a free energy of
77.3
kJ/mol. We used two models for analyzing the binding data. The first
model assumes a single Ca2+ binding site and is described
by the microscopic equilibrium dissociation constant
Kd. The second model assumes two binding sites and
is described by two macroscopic dissociation constants,
KD1 and
KD2. The values obtained for
KD1 and
KD2 allow to detect positive
cooperativity between the sites. If Ca2+ binding to any
site is independent from the occupation of the other site
(i.e. no cooperativity), KD2
will be equal or greater than 4 × KD1. If positive cooperativity is present between the sites, KD2 is
smaller than 4 × KD1 because the
second Ca2+ ion binds with higher affinity when one site is
already occupied by a Ca2+ ion. This model is an
alternative to the use of the Hill equation but allows more detailed
insight into the binding process and the energetics of binding
(44).
The experimental results for calcium binding to BM-40 could only be
fitted satisfactorily with the two-site model. The macroscopic dissociation constants, KD1 = 490 nM and KD2 = 57 nM, demonstrate that binding of the second Ca2+
ion is facilitated by positive cooperativity. A minimum interaction energy of
8.8 kJ/mol can be calculated from these values (Table I).
Because a signal specific for EF1 or EF2 cannot be obtained by circular
dichroism and fluorescence spectroscopy, it is not possible to know
whether the EF-hands become occupied sequentially in a defined order or
whether they bind Ca2+ in parallel. The macroscopic
dissociation constants can therefore not be attributed to the
individual EF-hands.
The failure to detect cooperative binding in our previous studies (33,
34) is now seen to have been caused by incomplete removal of
Ca2+ from BM-40 and buffer solutions. Thus,
Ca2+ titrations were started with partially saturated
proteins, and only the second halves of the saturation curves were
recorded. At the time, only one binding site had been predicted for
BM-40 (32, 50), and we therefore used a simple single-site model for
data evaluation, which happened to describe the experimental data
reasonably well. Of course, the data could also be fitted with more
complex models including cooperativity, but these models did not
produce a significantly better fit. In the present study, high accuracy
in the low nanomolar range could be achieved through the use of the
EGTA/CaEGTA system, finally allowing the single-site and the two-site
model with cooperativity to be clearly distinguished.
BM-40 is half-saturated at a free Ca2+ concentration of 170 nM. As already mentioned, free Ca2+
concentrations in serum and several other extracellular tissue fluids
are much higher (1.2 mM), but local gradients or changes in
the extracellular Ca2+ concentration down to 0.1 mM have been observed (49, 51, 52). Nevertheless, even at
the lowest extracellular Ca2+ concentrations reported to
date, the EF-hands in BM-40 will be in the fully
Ca2+-saturated form. This indicates that Ca2+
bound to the EF-hands in BM-40 is likely to play a structural rather
than a regulatory role. It is known that the structure maintained by
Ca2+ is essential for the binding of BM-40 to collagens,
and the collagen-binding site has indeed been mapped to the EC domain
(34, 35).
Nearly identical Ca2+ binding profiles were observed for
the FS-EC domain pair and for full-length BM-40, showing that the
acidic N-terminal domain I does not influence the affinity and
cooperativity of Ca2+ binding to the EC domain. In marked
contrast, when both domain I and the FS domain were deleted the free
energy of Ca2+ binding was increased by 7.8 kJ/mol to
69.5 kJ/mol, demonstrating a strong interaction between the FS and EC
domains. The first macroscopic dissociation constant,
KD1, was increased about 20-fold
compared with full-length BM-40, whereas the second constant,
KD2, was not affected. Interestingly,
the cooperativity between the EF-hands, as measured by 
G, is
higher in the isolated EC domain relative to FS-EC and full-length
BM-40 (Table I). Presumably, the strong interaction between the FS and
EC domain in FS-EC restricts the conformational changes in the EF-hands that accompany Ca2+ binding, whereas in the isolated EC
domain binding of the first equivalent of Ca2+ leads to a
relatively larger rearrangement. The second equivalent then binds to
similar structures in both FS-EC and EC, as evidenced by a similar
value of KD2.
The interface between the FS and EC domain is revealed in the structure
of the FS-EC domain pair (16). The relatively small domain interface
(550 Å2) is largely formed by
-strand 5 of the FS
domain and
-helix E of the EC domain, the second helix of EF1 (Fig.
9). A further contact between the FS
domain and EF1 involves His62 and His224, which
participates in the unusual cis-peptide bond in EF1. There are no direct contacts between the FS domain and EF2. A comparison of
the EF-hand structures in FS-EC domain pair and the isolated EC domain
does not reveal any significant differences that could explain the
large effect of the FS domain on Ca2+ binding. This is
perhaps not surprising, because both structures were determined under
saturating concentrations of Ca2+. The corresponding
Ca2+-free forms have so far defied a structure
determination, but we assume that because of the intimate contacts
between the FS domain and EF1, the EF-hands in Ca2+-free
FS-EC adopt a different structure than in the Ca2+-free EC
domain. EF1 is presumably predisposed for Ca2+ binding in
FS-EC, perhaps because the cis-trans equilibrium
of the His224-Pro225 peptide bond is pushed
toward the cis-conformation required for Ca2+
binding or because Glu234 is positioned appropriately. It
is thus tempting to associate KD1 in the
interpretation of our binding data with EF1 and
KD2 with EF2, although we stress again
that the macroscopic dissociation constants are not necessarily linked
to microscopic sequential events.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 9.
Structure of the interface of FS and EC
domains. The interface between the FS domain (green)
and the EC domain (light blue) is shown, based on the
crystal structure of FS-EC (16). The calcium ions are shown as
pink spheres. The disulfide bond between Cys256
and Cys272 is in yellow. Residues involved in
the domain interface are shown as atomic models, as are the glutamic
acids Glu234 and Glu268 at position Z in EF1
and EF2, respectively. The helices in the EF-hands are labeled
D-G. This figure was created with BOBSCRIPT (53, 54) and
RASTER3D (55).
|
|
To analyze the contributions of individual EF-hands to Ca2+
binding, we replaced the conserved glutamic acid at position
Z in
each EF-hand by lysine (Fig. 1). Although the mutant EC-EF1-E234K was
readily secreted from the human kidney cells used for recombinant expression, the EC domain with the corresponding mutation in the second
EF-hand, EC-EF2-E268K, as well as the double mutant
EC-EF1,2-E234K,E268K, could not be detected in the cell culture
supernatant. However, the corresponding mRNA as well as small
amounts of both proteins were present in cellular extracts (Fig. 4).
Apparently, mutation of the bidentate Ca2+ ligand
Glu268 in EF2 interfered with proper folding in the
endoplasmic reticulum, resulting in protein degradation. These results
point to a function of EF-hands in the folding and secretion of
extracellular EF-hand proteins. It remains to be elucidated whether
chaperones are involved in this process. To determine whether
Ca2+ binding to EF2 is strictly required for folding and
secretion of BM-40, we produced mutant EC-EF2-D257K, in which the
aspartic acid at position X was replaced by lysine. This mutant was
secreted from the cells. No cooperativity could be detected in the
Ca2+ titrations, and a model assuming a single binding site
with a dissociation constant of Kd = 205 µM fitted the data well. In the mutant EC-EF1-E234K,
cooperativity was also lost, and a dissociation constant of
Kd = 45 µM was obtained. Most
probably, the mutations decreased the Ca2+ affinity of the
affected site to such an extent that binding could no longer be
detected at the Ca2+ concentrations used. The remaining
Ca2+ binding thus represents binding to the nonmutated
EF-hand when the other hand in the pair is mutated. The dramatic,
several 100-fold reduction in Ca2+ affinity of the
nonmutated EF-hand is additional evidence for a strong coupling between
the two EF-hands, which underlies the cooperativity of Ca2+
binding. Further insight into the energetics of Ca2+
binding can be gained by comparing the effects of mutations in the EC
domain with those in full-length BM-40. Although the EF2-D257K mutation
strongly decreased the Ca2+ affinity when introduced in the
EC domain, the same mutation had only a small effect when introduced in
full-length BM-40 (Table I), supporting the interpretation that the FS
domain increases Ca2+ affinity in the EC domain mainly via
interactions with EF1. Interestingly, the interaction of the FS and EC
domains allows the mutant BM-40-EF2-E268K to be folded and secreted,
whereas the same mutation in the isolated EC domain abolished secretion.
In conclusion, our results show that the EF-hands in the extracellular
protein BM-40 bind Ca2+ cooperatively and with high
affinity, just like their counterparts in cytosolic proteins. However,
an additional layer of complexity is introduced by the presence of the
FS domain, which physically interacts with the variant EF-hand 1 and,
therefore, is intimately involved in Ca2+ binding to the EC domain.
 |
FOOTNOTES |
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant Ma 1932/1-1 (to P. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Wellcome Trust Senior Research Fellow.
**
To whom correspondence should be addressed: Inst. for Biochemistry,
Medical Faculty, University of Cologne, Joseph-Stelzmann-Str. 52, 50931 Cologne, Germany.
Published, JBC Papers in Press, May 2, 2000, DOI 10.1074/jbc.M001770200
 |
ABBREVIATIONS |
The abbreviations used are:
RT, reverse
transcription;
PCR, polymerase chain reaction;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
| 1.
|
Klee, C. B.
(1988)
in
Calmodulin
(Cohen, P.
, and Klee, C. B., eds)
, pp. 35-56, Elsevier, New York
|
| 2.
|
Pochet, R.,
Lawson, D. E.,
and Heizmann, C. W.
(1990)
Ca2+-binding Proteins in Normal and Transformed Cells
, Plenum Press, New York
|
| 3.
|
Schäfer, B. W.,
and Heizmann, C. W.
(1996)
Trends Biochem.
21,
134-140
|
| 4.
|
Donati, R.
(1999)
Biochem. Biophys. Acta
1450,
191-231
|
| 5.
|
Kretsinger, R. H.,
and Nockolds, C. E.
(1973)
J. Biol. Chem.
248,
3313-3326
|
| 6.
|
McPhalen, C. A.,
Strynadcka, N. C. J.,
and James, M. N. G.
(1991)
Adv. Protein Chem.
42,
77-144
|
| 7.
|
Falke, J. J.,
Drake, S. K.,
Hazard, A. L.,
and Peersen, O. B.
(1994)
Q. Rev. Biophys.
27,
219-290
|
| 8.
|
Nelson, M. R.,
and Chazin, W. J.
(1998)
Biometals
11,
297-318
|
| 9.
|
Szebenyi, D. M.,
Obendorf, S. K.,
and Moffat, K.
(1981)
Nature
294,
S327-332
|
| 10.
|
Linse, S.,
Brodin, P.,
Drakenberg, T.,
Thulin, E.,
Sellers, P.,
Elmden, K.,
Grundström, T.,
and Forsén, S.
(1987)
Biochemistry
26,
6723-6735
|
| 11.
|
Xie, X.,
Harrison, D. H.,
Schlichting, I.,
Sweet, R. M.,
Kalabokis, V. N.,
Szent-Gyorgyi, A. G.,
and Cohen, C.
(1994)
Nature
368,
306-312
|
| 12.
|
Houdusse, A.,
and Cohen, C.
(1996)
Structure
4,
21-32
|
| 13.
|
Blanchard, H.,
Grochulski, P.,
Li, Y.,
Arthur, S. C.,
Davies, P. L.,
Elce, J. S.,
and Cygler, M.
(1997)
Nat. Struct. Biol.
4,
532-538
|
| 14.
|
Lin, G.,
Chattopadhyay, D.,
Maki, M.,
Wang, K. K. W.,
Carson, M.,
Jin, L.,
Yuen, P.,
Takano, E.,
Hatanaka, M.,
DeLucas, L. J.,
and Narayana, S. V. L.
(1997)
Nat. Struct. Biol.
4,
539-547
|
| 15.
|
Hohenester, E.,
Maurer, P.,
and Timpl, R.
(1997)
EMBO J.
16,
3778-3786
|
| 16.
|
Hohenester, E.,
Maurer, P.,
Hohenadl, C.,
Timpl, R.,
Jansonius, J. N.,
and Engel, J.
(1996)
Nat. Struct. Biol.
3,
67-73
|
| 17.
|
Lane, T. F.,
and Sage, E. H.
(1994)
FASEB J.
8,
163-173
|
| 18.
|
Ledda, M. F.,
Adris, S.,
Bravo, A. I.,
Kairiyama, C.,
Bover, L.,
Chernajovsky, Y.,
Mordoh, J.,
and Podhajcer, O. L.
(1997)
Nat. Med.
3,
171-176
|
| 19.
|
Schwarzbauer, J. E.,
and Spencer, C. S.
(1993)
Mol. Biol. Cell
4,
941-952
|
| 20.
|
Fitzgerald, M. C.,
and Schwarzbauer, J. E.
(1998)
Curr. Biol.
8,
1285-1288
|
| 21.
|
Purcell, L.,
Gruia-Gray, J.,
Scanga, S.,
and Ringuette, M.
(1993)
J. Exp. Zool.
265,
153-164
|
| 22.
|
Damjanovski, S.,
Karp, X.,
Funk, S.,
Sage, E. H.,
and Ringuette, M. J.
(1997)
J. Histochem. Cytochem.
45,
643-655
|
| 23.
|
Gilmour, D. T.,
Lyon, G. J,
Carlton, M. B.,
Sanes, J. R.,
Cunningham, J. M.,
Anderson, J. R.,
Hogan, B. L.,
Evans, M. J.,
and Colledge, W. H.
(1998)
EMBO J.
17,
1860-1870
|
| 24.
|
Norose, K.,
Clark, J. I.,
Syed, N. A.,
Basu, A.,
Heber-Katz, E.,
Sage, E. H.,
and Howe, C. C.
(1998)
Invest. Ophthalmol. Vis. Sci.
39,
2674-2680
|
| 25.
|
Delany, A.,
Amling, M.,
Priemel, M.,
Delling, G.,
Howe, C.,
Baron, R.,
and Canalis, E.
(1998)
Bone
23,
199S
|
| 26.
|
Johnston, I. G.,
Paladino, T.,
Gurd, J. W.,
and Brown, I. R.
(1990)
Neuron
2,
165-176
|
| 27.
|
Guermah, M.,
Crisanti, P.,
Laugier, D.,
Dezelee, P.,
Bidou, L.,
Pessac, B.,
and Calothy, G.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4503-4507
|
| 28.
|
Shibanuma, M.,
Mashimo, J.,
Mita, A.,
Kuroki, T.,
and Nose, K.
(1993)
Eur. J. Biochem.
217,
13-19
|
| 29.
|
Alliel, P. M.,
Perin, J. P.,
Jollès, P.,
and Bonnet, F. J.
(1993)
Eur. J. Biochem.
214,
347-350
|
| 30.
|
Vannahme, C.,
Schübel, S.,
Herud, M.,
Gösling, S.,
Hülsmann, H.,
Paulsson, M.,
Hartmann, U.,
and Maurer, P.
(1999)
J. Neurochem.
73,
12-20
|
| 31.
|
Maurer, P.,
Mayer, U.,
Bruch, M.,
Jenö, P.,
Mann, K.,
Landwehr, R.,
Engel, J.,
and Timpl, R.
(1992)
Eur. J. Biochem.
205,
233-240
|
| 32.
|
Engel, J.,
Taylor, W.,
Paulsson, M.,
Sage, H.,
and Hogan, B.
(1987)
Biochemistry
26,
6958-6965
|
| 33.
|
Pottgiesser, J.,
Maurer, P.,
Mayer, U.,
Nischt, R.,
Mann, K.,
Timpl, R.,
Krieg, T.,
and Engel, J.
(1994)
J. Mol. Biol.
238,
563-574
|
| 34.
|
Maurer, P.,
Hohenadl, C.,
Hohenester, E.,
Göhring, W.,
Timpl, R.,
and Engel, J.
(1995)
J. Mol. Biol.
253,
347-57
|
| 35.
|
Sasaki, T.,
Hohenester, E.,
Göhring, W.,
and Timpl, R.
(1998)
EMBO J.
17,
1625-1634
|
| 36.
|
Lankat-Buttgereit, B.,
Mann, K.,
Deutzmann, R.,
Timpl, R.,
and Krieg, T.
(1988)
FEBS Lett.
236,
352-356
|
| 37.
|
Deng, W. P.,
and Nickoloff, J. A.
(1992)
Anal. Biochem.
200,
81-88
|
| 38.
|
Kohfeldt, E.,
Maurer, P.,
Vannahme, C.,
and Timpl, R.
(1997)
FEBS Lett.
414,
557-561
|
| 39.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 40.
|
Nischt, R.,
Pottgiesser, J.,
Krieg, T.,
Mayer, U.,
Aumailley, M.,
and Timpl, R.
(1991)
Eur. J. Biochem.
200,
529-536
|
| 41.
|
Gill, S. C.,
and von Hippel, P. H.
(1989)
Anal. Biochem.
182,
319-326
|
| 42.
|
Tsien, R.,
and Pozzan, T.
(1989)
Methods Enzymol.
172,
230-262
|
| 43.
|
Eberhard, M.
(1990)
Comput. Appl. Biosci.
6,
213-221
|
| 44.
|
Linse, S.,
and Chazin, W. J.
(1995)
Protein Sci.
4,
1038-1044
|
| 45.
|
Maune, J. F.,
Beckingham, K.,
Martin, S. R.,
and Bayley, P. M.
(1992)
Biochemistry
31,
7779-7786
|
| 46.
|
Maune, J. F.,
Klee, C. B.,
and Beckingham, K.
(1992)
J. Biol. Chem.
267,
5286-5295
|
| 47.
|
Gao, Z. H.,
Krebs, J.,
Van Berkum, M. F.,
Tang, W. J.,
Maune, J. F.,
Means, A. R.,
Stull, J. T.,
and Beckingham, K.
(1993)
J. Biol. Chem.
268,
20096-200104
|
| 48.
|
Zhao, Y.,
Pokutta, S.,
Maurer, P.,
Lindt, M.,
Franklin, R. M.,
and Kappes, B.
(1994)
Biochemistry
33,
3714-3721
|
| 49.
|
Maurer, P.,
and Hohenester, E.
(1997)
Matrix Biol.
15,
569-580
|
| 50.
|
Kretsinger, R. H.,
Tolbert, D.,
Nakayama, S.,
and Pearson, W.
(1991)
in
Novel Calcium-binding Proteins
(Heizmann, C. W., ed)
, pp. 17-37, Springer-Verlag New York Inc., New York
|
| 51.
|
Nicholson, C.
(1980)
Fed. Proc.
39,
1519-1523
|
| 52.
|
Brown, E. M.,
Vassilev, P. M.,
and Hebert, S. C.
(1995)
Cell
83,
679-682
|
| 53.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950
|
| 54.
|
Esnouf, R. M.
(1997)
J. Mol. Graph.
15,
132-134
|
| 55.
|
Merritt, E. A.,
and Murphy, M. E. P.
(1994)
Acta Crystallogr. Sect. D Biol. Crystallogr.
50,
869-873
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Martinek, J. Shahab, J. Sodek, and M. Ringuette
Is SPARC an Evolutionarily Conserved Collagen Chaperone?
J. Dent. Res.,
April 1, 2007;
86(4):
296 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. T. Keutmann, A. L. Schneyer, and Y. Sidis
The Role of Follistatin Domains in Follistatin Biological Action
Mol. Endocrinol.,
January 1, 2004;
18(1):
228 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Sage, M. Reed, S. E. Funk, T. Truong, M. Steadele, P. Puolakkainen, D. H. Maurice, and J. A. Bassuk
Cleavage of the Matricellular Protein SPARC by Matrix Metalloproteinase 3 Produces Polypeptides That Influence Angiogenesis
J. Biol. Chem.,
September 26, 2003;
278(39):
|